Net Cash Provided by (Used in) Financing Activities of IDEXX LABORATORIES INC /DE from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
IDEXX LABORATORIES INC /DE annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • IDEXX LABORATORIES INC /DE Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $330,321,000, a 129% decline year-over-year.
  • IDEXX LABORATORIES INC /DE annual Net Cash Provided by (Used in) Financing Activities for 2025 was $1,164,964,000, a 33% decline from 2024.
  • IDEXX LABORATORIES INC /DE annual Net Cash Provided by (Used in) Financing Activities for 2024 was $878,073,000, a 99% decline from 2023.
  • IDEXX LABORATORIES INC /DE annual Net Cash Provided by (Used in) Financing Activities for 2023 was $441,996,000, a 19% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

IDEXX LABORATORIES INC /DE Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,164,964,000 -$286,891,000 -33% 01 Jan 2025 31 Dec 2025 10-K 20 Feb 2026 2025 FY
2024 $878,073,000 -$436,077,000 -99% 01 Jan 2024 31 Dec 2024 10-K 20 Feb 2026 2025 FY
2023 $441,996,000 -$71,060,000 -19% 01 Jan 2023 31 Dec 2023 10-K 20 Feb 2026 2025 FY
2022 $370,936,000 +$326,478,000 +47% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 $697,414,000 -$448,998,000 -181% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $248,416,000 +$37,993,000 +13% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
2019 $286,409,000 +$311,390,000 +52% 01 Jan 2019 31 Dec 2019 10-K 16 Feb 2022 2021 FY
2018 $597,799,000 -$389,783,000 -187% 01 Jan 2018 31 Dec 2018 10-K 12 Feb 2021 2020 FY
2017 $208,016,000 01 Jan 2017 31 Dec 2017 10-K 14 Feb 2020 2019 FY
2014 $103,438,000 -$987,000 -0.96% 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2015 2014 FY
2013 $102,451,000 +$22,892,000 +18% 01 Jan 2013 31 Dec 2013 10-K 17 Feb 2015 2014 FY
2012 $125,343,000 -$27,686,000 -28% 01 Jan 2012 31 Dec 2012 10-K 17 Feb 2015 2014 FY
2011 $97,657,000 -$10,888,000 -13% 01 Jan 2011 31 Dec 2011 10-K 18 Feb 2014 2013 FY
2010 $86,769,000 01 Jan 2010 31 Dec 2010 10-K 19 Feb 2013 2012 FY

IDEXX LABORATORIES INC /DE Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $330,321,000 -$186,247,000 -129% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $144,074,000 +$2,007,000 +1.4% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q1 2023 $146,081,000 -$132,601,000 -984% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024 2024 Q1
Q1 2022 $13,480,000 +$116,171,000 +90% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q1 2021 $129,651,000 -$146,552,000 -867% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $16,901,000 +$19,682,000 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $2,781,000 +$322,210,000 +99% 01 Jan 2019 31 Mar 2019 10-Q 30 Apr 2020 2020 Q1
Q1 2018 $324,991,000 -$326,304,000 -24852% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019 2019 Q1
Q1 2017 $1,313,000 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q1 2015 $36,801,000 +$51,761,000 01 Jan 2015 31 Mar 2015 10-Q 28 Apr 2015 2015 Q1
Q1 2014 $14,960,000 -$17,212,000 -764% 01 Jan 2014 31 Mar 2014 10-Q 28 Apr 2015 2015 Q1
Q1 2013 $2,252,000 +$8,816,000 01 Jan 2013 31 Mar 2013 10-Q 25 Apr 2014 2014 Q1
Q1 2012 $6,564,000 +$16,886,000 +72% 01 Jan 2012 31 Mar 2012 10-Q 23 Apr 2013 2013 Q1
Q1 2011 $23,450,000 -$13,846,000 -144% 01 Jan 2011 31 Mar 2011 10-Q 20 Apr 2012 2012 Q1
Q1 2010 $9,604,000 01 Jan 2010 31 Mar 2010 10-Q 21 Apr 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.